PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism.

PTEN is one of the most frequently mutated genes in human cancer. It is known that PTEN has a wide range of biological functions beyond tumor suppression. Here, we report that PTENα, an N-terminally extended form of PTEN, functions in mitochondrial metabolism. Translation of PTENα is initiated from a CUG codon upstream of and in-frame with the coding region of canonical PTEN. Eukaryotic translation initiation factor 2A (eIF2A) controls PTENα translation, which requires a CUG-centered palindromic motif. We show that PTENα induces cytochrome c oxidase activity and ATP production in mitochondria. TALEN-mediated somatic deletion of PTENα impairs mitochondrial respiratory chain function. PTENα interacts with canonical PTEN to increase PINK1 protein levels and promote energy production. Our studies demonstrate the importance of eIF2A-mediated alternative translation for generation of protein diversity in eukaryotic systems and provide insights into the mechanism by which the PTEN family is involved in multiple cellular processes.

[1]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[2]  Carlos Cordon-Cardo,et al.  Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.

[3]  S. Ficarro,et al.  cAMP-dependent Tyrosine Phosphorylation of Subunit I Inhibits Cytochrome c Oxidase Activity* , 2005, Journal of Biological Chemistry.

[4]  P. Pandolfi,et al.  Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State , 2012, Cell.

[5]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[6]  Yuxin Yin,et al.  PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression , 2003, Nature.

[7]  D. Peabody,et al.  Translation initiation at non-AUG triplets in mammalian cells. , 1989, The Journal of biological chemistry.

[8]  N. Shastri,et al.  Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I , 2012, Science.

[9]  J. Smeitink,et al.  Mitochondrial oxidative phosphorylation system assembly in man: recent achievements , 2001, Current opinion in neurology.

[10]  M. Kozak.  Initiation of translation in prokaryotes and eukaryotes. , 1999, Gene.

[11]  Jennifer S. Yu,et al.  A Secreted PTEN Phosphatase That Enters Cells to Alter Signaling and Survival , 2013, Science.

[12]  V. Zhurkin,et al.  Mitogen-activated protein kinase phosphatase 2: a novel transcription target of p53 in apoptosis. , 2006, Cancer research.

[13]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[14]  G. Mills,et al.  MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. , 1997, Cancer research.

[15]  T. Sanderson,et al.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease. , 2012, Advances in experimental medicine and biology.

[16]  Weibin Chen,et al.  Improving de novo sequencing of peptides using a charged tag and C-terminal digestion. , 2007, Analytical chemistry.

[17]  C. Cordon-Cardo,et al.  Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Gasser.  Update on the genetics of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[19]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[20]  N. Shastri,et al.  Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. , 1999, Immunity.

[21]  P. Pandolfi,et al.  Essential Role for Nuclear PTEN in Maintaining Chromosomal Integrity , 2007, Cell.

[22]  R. Youle,et al.  Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.

[23]  Tak W. Mak,et al.  The ER UDPase ENTPD5 Promotes Protein N-Glycosylation, the Warburg Effect, and Proliferation in the PTEN Pathway , 2010, Cell.

[24]  B. Stiles,et al.  Selective Deletion of Pten in Pancreatic β Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes , 2006, Molecular and Cellular Biology.

[25]  Tomohiko Maehama,et al.  The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[26]  T. Mak,et al.  High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.

[27]  R. Eisenman,et al.  A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas , 1988, Cell.

[28]  M. Palkovits,et al.  Unconventional translation initiation of human trypsinogen 4 at a CUG codon with an N‐terminal leucine , 2007, The FEBS journal.

[29]  R. Sherwin,et al.  Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jing-jing Wu,et al.  DUSP1 Is Controlled by p53 during the Cellular Response to Oxidative Stress , 2008, Molecular Cancer Research.

[31]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[32]  Jill L. Wegrzyn,et al.  Bioinformatic analyses of mammalian 5'-UTR sequence properties of mRNAs predicts alternative translation initiation sites , 2008, BMC Bioinformatics.

[33]  T. Mak,et al.  High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. , 2000, Cancer research.

[34]  Pier Paolo Pandolfi,et al.  Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner , 2011, Cell.

[35]  M. Nelen,et al.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.

[36]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[37]  V. Gladyshev,et al.  CUG Start Codon Generates Thioredoxin/Glutathione Reductase Isoforms in Mouse Testes*♦ , 2009, Journal of Biological Chemistry.

[38]  J. Watson,et al.  Protein sequencing by matrix-assisted laser desorption ionization-postsource decay-mass spectrometry analysis of the N-Tris(2,4,6-trimethoxyphenyl)phosphine-acetylated tryptic digests. , 1999, Analytical biochemistry.